About
Technology
Issues
FAQ
Links
Official Page
Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.